Suboptimal usage of proton pump inhibitors common

Suboptimal usage of proton pump inhibitors common

(HealthDay)—For patients with gastroesophageal reflux disease (GERD), those who receive a proton pump inhibitor (PPI) prescription from gastroenterologists are more likely to be optimal users and have better symptom control, according to a study published in the June issue of the American Journal of Gastroenterology.

Imran Sheikh, M.D., from Case Western Reserve University in Cleveland, and colleagues surveyed 1,959 patients with GERD at five clinics to assess dosing patterns and symptom control in over-the-counter (OTC) and prescription PPI users. Participants were surveyed regarding GERD diagnosis, use of PPIs, information on dosing, demographics, and Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS).

The researchers found that 31 percent of participants used PPIs for GERD. Of these, 32 percent purchased OTC PPIs, while 31 and 37 percent, respectively, received prescriptions from gastroenterologists and . Optimal use was reported by 71 percent of those prescribed PPIs by gastroenterologists, compared with 47 percent of those receiving prescriptions from primary care providers and 39 percent of consumers (both P < 0.001). Patients prescribed PPIs by gastroenterologists had significant better GSAS symptom, frequency, and severity scores (all P < 0.001, compared with provider and consumer). Patients using PPIs optimally had significantly better GSAS symptom, frequency, and severity scores, compared with those taking PPIs suboptimally or excessively (all parameters, P < 0.001).

"Patients receiving prescription PPI from a gastroenterologist are more likely to be optimal users with better symptom control," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Many patients keep using PPIs after negative GERD test

Jun 05, 2012

(HealthDay) -- Nearly half of patients continue to use proton pump inhibitors (PPIs) even after pH studies confirm that they do not have gastroesophageal reflux disease (GERD), and most do not recall being ...

Prescription problems for vets on reflux drug

Feb 20, 2013

U.S. veterans diagnosed with gastroesophageal reflux disease (GERD) are frequently prescribed doses of proton pump inhibitors (PPIs), such as omeprazole (commonly known by brand names such as Prilosec), that are much higher ...

Recommended for you

Restrictions lifted at British bird flu farm

16 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.